Allogeneic bone marrow transplantation in hematologic disorders of childhood: new trends and controversies.
Bone marrow transplantation (BMT) represents an important therapeutic choice for several kinds of disorders: hematologic, metabolic and neoplastic pathologies can be treated with this strategy. The aim of this article is to describe the main indications for allogeneic BMT in haematologic disorders of childhood and possible problems related to this procedure. We consider only hematologic aspects, paying particular attention to unusual disorders of infancy as myelodysplastic syndromes and aplastic anemia. We also consider quality of life after a BMT in patients with sickle cell anemia and thalassemia major and compare this with quality of life of patients receiving chronic periodic blood transfusions.
Barth
E
E
Dipartimento di Scienze della Riproduzione e dello Sviluppo, Sezione di Emato-oncologia Pediatrica, IRCCS Burlo Garofolo, Trieste, Italy.
Malorgio
C
C
Tamaro
P
P
D016026:Bone Marrow Transplantation / Q000639:trends; D002648:Child; D002675:Child, Preschool; D006402:Hematologic Diseases / Q000628:therapy*; D006801:Humans